Clinical Research

Clinical Trials Drug Efficacy Drug Trials Drug Development Randomized Controlled Trials Psychedelic Research Efficacy Studies Systematic Reviews Epidemiology Drug Studies

3 ARTICLES

6d ago

Medsafe Authorises Two Psychiatrists to Give MDMA Therapy for Severe PTSD

The narrow approvals let experienced clinicians administer pharmaceutical‑grade MDMA in clinic settings, a cautious regulatory opening that may reshape access to PTSD care.

3 ARTICLES

4w ago

FDA to Convene Advisory Panel to Review Grail’s Galleri Cancer Screening Test

5 ARTICLES

last mo.

Psilocybin Therapy Puts Most Veterans With Treatment‑Resistant PTSD Into Remission

3 ARTICLES

3mo ago

FDA Approves Xocova as First U.S. Post-Exposure COVID-19 Antiviral

3 ARTICLES

5mo ago

Semaglutide Patents Lapse in India and China as Safety Scrutiny Rises

3 ARTICLES

6mo ago

FDA Approves Teclistamab–Daratumumab Combination for Relapsed Multiple Myeloma After One Prior Therapy

3 ARTICLES

7mo ago

FDA Grants Priority Review to Otsuka’s ADHD Drug Centanafadine With July 24 Decision Date

3 ARTICLES

8mo ago

AstraZeneca Withdraws Andexxa From U.S. Market After FDA Says Risks Outweigh Benefits

4 ARTICLES

8mo ago

Smartwatch Alerts Halve Severe Tantrums in Mayo Clinic Randomized Trial

4 ARTICLES

9mo ago

Daré Bioscience Launches Topical Sildenafil Cream for Female Arousal

4 ARTICLES

10mo ago

Single Psilocybin Dose Plus Mindfulness Eases Depression for Frontline Clinicians in Randomized Trial

3 ARTICLES

10mo ago

NMC Clears 10,650 MBBS Seats and 41 New Colleges, Taking India’s Total to 137,600

3 ARTICLES

10mo ago

WeightWatchers Taps Amazon Pharmacy for Faster GLP-1 Access and Delivery

3 ARTICLES

10mo ago

App-Based Relaxation Nearly Doubles Rate of Disability Improvement for ED Migraine Patients

4 ARTICLES

11mo ago

MHRA Reforms and AI Cut UK Clinical Trial Approval Times to 41 Days

3 ARTICLES

11mo ago

Mayo Clinic Launches Platform_Orchestrate as a Single Front Door for Faster Clinical Development

4 ARTICLES

11mo ago

FDA Authorizes Essilor’s Stellest Lens, First U.S. Spectacle Lens Shown to Slow Childhood Myopia

3 ARTICLES

11mo ago

FDA Launches New Safety Review of Abortion Pill Mifepristone

3 ARTICLES

11mo ago

FDA Opens Door to Reconsider Capricor’s Duchenne Cell Therapy Based on HOPE-3 Data

4 ARTICLES

11mo ago

Green-Mediterranean Diet Tied to Slower Brain Aging Markers in 18-Month Trial

Clinical Research

Medsafe Authorises Two Psychiatrists to Give MDMA Therapy for Severe PTSD

FDA to Convene Advisory Panel to Review Grail’s Galleri Cancer Screening Test

Psilocybin Therapy Puts Most Veterans With Treatment‑Resistant PTSD Into Remission

FDA Approves Xocova as First U.S. Post-Exposure COVID-19 Antiviral

Semaglutide Patents Lapse in India and China as Safety Scrutiny Rises

FDA Approves Teclistamab–Daratumumab Combination for Relapsed Multiple Myeloma After One Prior Therapy

FDA Grants Priority Review to Otsuka’s ADHD Drug Centanafadine With July 24 Decision Date

AstraZeneca Withdraws Andexxa From U.S. Market After FDA Says Risks Outweigh Benefits

Smartwatch Alerts Halve Severe Tantrums in Mayo Clinic Randomized Trial

Daré Bioscience Launches Topical Sildenafil Cream for Female Arousal

Never miss stories about

Clinical Research

Single Psilocybin Dose Plus Mindfulness Eases Depression for Frontline Clinicians in Randomized Trial

NMC Clears 10,650 MBBS Seats and 41 New Colleges, Taking India’s Total to 137,600

WeightWatchers Taps Amazon Pharmacy for Faster GLP-1 Access and Delivery

App-Based Relaxation Nearly Doubles Rate of Disability Improvement for ED Migraine Patients

MHRA Reforms and AI Cut UK Clinical Trial Approval Times to 41 Days

Mayo Clinic Launches Platform_Orchestrate as a Single Front Door for Faster Clinical Development

FDA Authorizes Essilor’s Stellest Lens, First U.S. Spectacle Lens Shown to Slow Childhood Myopia

FDA Launches New Safety Review of Abortion Pill Mifepristone

FDA Opens Door to Reconsider Capricor’s Duchenne Cell Therapy Based on HOPE-3 Data

Green-Mediterranean Diet Tied to Slower Brain Aging Markers in 18-Month Trial

Never miss stories about

Clinical Research